Neurologic complications and outcomes of infective endocarditis in critically ill patients: The ENDOcardite en REAnimation prospective multicenter study*
Infective Endocarditis
Stroke
DOI:
10.1097/ccm.0b013e3182120b41
Publication Date:
2011-02-25T08:17:57Z
AUTHORS (19)
ABSTRACT
Objective: To describe the clinical spectrum of infective endocarditis in critically ill patients and assess impact neurologic complications on outcomes. Design: Prospective multicenter observational study conducted from April 2007 to October 2008. Setting: Thirty-three intensive care units 23 university-affiliated 10 general French hospitals. Patients: Two hundred twenty-five with definite IE were studied. Factors associated predictors 3-month mortality identified by logistic regression analysis. Functional outcomes evaluated modified Rankin Scale. Interventions: None. Measurements Main Results: Among 198 left-sided endocarditis, 108 (55%) experienced at least one complication. These ischemic stroke (n = 79), cerebral hemorrhage 53), meningitis or meningeal reaction 41), brain abscess 14), mycotic aneurysm 10). independently (subhazard ratio [95% confidence interval]): Staphylococcus aureus (1.45 [1.02–2.05]), mitral valve (1.54 [1.07–2.21]), nonneurologic embolic events (1.51 [1.09–2.09]). In contrast, health care-associated had a protective effect (0.46 [0.27–0.77]). Multivariate analysis three variables (odds failure, as defined Glasgow Coma Scale <10 (7.41 [2.89–18.96]), S. (3.26 [1.53–6.94]), severe comorbidities before admission Charlson score >2 (3.16 [1.47–6.77]). 106 assessed follow-up (3.9 [3–8.5] months), 31 (29%) ≤3 (ability walk without assistance), nine (9%) 4 5 (severe disability), 66 (62%) 6 (death). Conclusions: Neurologic are most frequent requiring unit admission. They contribute prognosis, leaving less than one-third alive functional independence. failure represents major determinant regardless underlying
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (139)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....